Biotech: Page 50
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
Taking Inspiration to the Next Level This is our favorite issue of the year, and we hope it’s yours too. It has been a joy and a privilege to have had a chance to get to know this year’s PharmaVOICE 100. They certainly illustrate what it means to think bigger, do more, and lead with passion and i...
By Taren Grom • July 26, 2011 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: A Changing Rhythm
According to Barbara Wirostko, M.D., chief medical officer for Altheos, the question of whether a product candidate will be reimbursed by government and third-party payers is now surfacing in the earliest stages of discovery. “Because there are now issues around who is going to reimburse and who ...
By PharmaVoice Team • May 24, 2011 -
Explore the Trendlineâž”
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Educating the Scientists of the Future
High-quality science education is critical for the success of pharmaceutical and biotechnology companies, not only to meet the need for scientists in the future but also to foster scientific Âliteracy. Education reform is a hot-button issue for the nation in general and the pharmaceutical industr...
By Denise Myshko • May 24, 2011 -
PharmaVoice Team/PharmaVoice
DIA Preview
New Tools, Services, and Products Designed to Improve Drug Development This special Drug Information Association section highlights the new and innovative products being offered by Âcompanies exhibiting at the upcoming 2011 DIA — 47th Annual Meeting in Chicago. (Note: briefs are listed alphabetic...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
Last Word
Combating Drug Resistance Roger Pomerantz, M.D., Senior VP and Head of Infectious Disease Research at Merck, talks about why antimicrobial resistance is a major global concern. PV: How big of a problem is antimicrobial Âresistance? Pomerantz: For the first time since the antibiotic era started in...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Dr. Janet HAMMOND Roche Strengthens Translational Medicine Leadership Roche has appointed Janet Hammond, M.D., Ph.D., VP, translational medicine – virology in pharmaceutical research and early development (pRED). Dr. Hammond joins Roche from Valeant Pharmaceuticals Internation...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
Ahn Nyeong: South Korea Emerges
In just three years, South Korea has been reclassified from an emerging market to a developed market by IMS. This is based on South Korea’s GDP level, as well as a well-established and growing economy, rising income levels, better living conditions, and an improved healthcare system that has led ...
By Kim Ribbink • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Partnering for Diagnostics
Molecular diagnostics, one of the fastest growing segments in the diagnostics market, are key enablers in delivering personalized medicine. According to industry consultants, molecular diagnostics are set to become the dominant platform in clinical medicine. But currently only about 10% of labels...
By Denise Myshko • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Creating a Personalized Medicine Strategy
Considered broadly, healthcare is personal. The goal of medical practitioners has always been to get the right drug to the right person at the right time at the right dose. But now industry experts say personalized medicine is at a tipping point as a multitude of factors converge, including advan...
By Denise Myshko • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Last Word
John Gargiulo, Daiichi Sankyo’s new President and CEO, discusses the future opportunities for the company and the industry. Keeping the Patient Front and Center Last Word PV: What are your goals for Daiichi Sanyko? Gargiulo: The healthcare industry is currently experiencing unprecedented challeng...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
UpFront
America’s biopharmaceutical Âresearch companies invested a record $67.4 billion last year in R&D, an increase of $1.5 billion. Healthcare Providers Say Pharma Provides Value Almost 8 out of 10 physicians view pharmaceutical companies and their sales reps as useful sources of information on Âm...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The mHealth Revolution The Statistics are staggering. According to a report by research2guidance, by 2015 one in five people around the world will have a smartphone. Another report states that mobile app revenue is expected to reach $35 billion by 2014. Finally, company investment in mobile phone...
By Taren Grom • April 25, 2011 -
PharmaVoice Team/PharmaVoice
The Era of Biosimilars
Although healthcare reform paved the way for a regulatory pathway for biosimilars, the Âbiopharmaceutical industry is facing a world of uncertainty as developers and regulators Ânavigate their way through this shifting Âlandscape. Biosimilar Defined » A “biosimilar" is a biological product that i...
By Denise Myshko • March 29, 2011 -
PharmaVoice Team/PharmaVoice
Privyet! Russia: Growth and Opportunity
With its promise of expansion, its population of around 140 million potential customers, and a pool of highly qualified staff, Russia has long been recognized as an important market for pharmaceutical companies. The pharma market in Russia has shown stable annual growth of 13% to 20% for several ...
By Kim Ribbink • March 28, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Steve FRY Dr. Sue MAHONY Lilly Announces Leadership Shifts Lilly has promoted Steve Fry to senior VP of human resources and diversity. Mr. Fry was previously VP of human resources for two of Lilly’s business areas, biomedicines and emerging markets. Mr. Fry succeeds Sue Mahony...
By PharmaVoice Team • March 28, 2011 -
PharmaVoice Team/PharmaVoice
UpFront
» Scott Weintraub Honored Scott Weintraub, founding Âprinciple of Healthcare ÂRegional Marketing, has been selected for the 2010 ÂOutstanding Leadership ÂRecognition Award by the U.S. ÂLeaders and Entrepreneur’s ÂAssociation (USLEA). The USLEA Awards Program recognizes highly regarded individuals...
By PharmaVoice Team • March 28, 2011 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Price of Success THE COST OF INNOVATION. The recent article published in the Feb. 7, 2011, issue of the journal BioSocieties for The London School of Economics and Political Science is causing quite a stir. The authors — Donald W. Light of Stanford University and University of Medicine and De...
By Taren Grom • March 28, 2011 -
PharmaVoice Team/PharmaVoice
Thought Leaders
Ryan Abbate. President, Pacific ÂCommunications, a healthcare communications agency that Âoffers strategic and tactical communications solutions. For more information, visit  Âpacific-com.com. Edward Abrahams, Ph.D. President,The Personalized ÂMedicine Coalition, which brings together the academ...
By PharmaVoice Team • March 7, 2011 -
PharmaVoice Team/PharmaVoice
Technology at the Speed of Light
The impact that the Internet and follow-on technologies have had on all areas of the life-sciences is well-documented throughout this special section, and the majority of our thought leaders have identified this as the biggest game changer in the last 10 years. Going even further, these same thou...
By PharmaVoice Team • March 7, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Dr. Robert CUDDIHY Sanofi-Aventis Adds to Diabetes Team Sanofi-Aventis U.S. has appointed Robert Cuddihy, M.D., VP, medical diabetes head in the U.S. Dr. Cuddihy is responsible for developing and executing the U.S. medical affairs strategy for Sanofi-Aventis’s diabetes divisio...
By PharmaVoice Team • March 3, 2011 -
PharmaVoice Team/PharmaVoice
What's New
Through its recent acquisition of MedPage Today, a news organization serving healthcare professionals, Everyday Health has added a significant offering for healthcare professionals to its portfolio of consumer health information brands. MedPage provides healthcare professionals with peer-reviewed...
By PharmaVoice Team • March 3, 2011 -
PharmaVoice Team/PharmaVoice
Digital Marketing: Dare to be Different
Research shows creativity is one of the most important components of a successful campaign, however, our experts say there are several other elements behind a campaign that need to be present to make the best of what digital media have to offer. Among them are matching the audience with the most ...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Robert DAVIS Dr. Ludwig HANTSON Baxter International Forms Medical Products Business Baxter International has appointed Robert Davis corporate VP and president of its newly created medical products business, which combines the company’s renal and medication delivery businesses...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
UpFront
Awards… Cephalon wins PRSA Awards CRF Health Wins at Clio Natrel Wins Rx Club Award INDUSTRY at Large Smarty Apps… E-Promotion on the E-Rise Supporting Science Education Lucky 14 Pharma Saves Green by Going Green Disruptive Technology, Disruptive times Top Innovators Podcasts Best Practices for Y...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Emerging Market: Ola Brazil
With every passing year, the pharmaceutical industry becomes more global in its  outlook and reach. In recognition of our shrinking world, PharmaVOICE is taking you on a journey across the globe. Our first stop is Latin America’s largest market, Brazil. Brazil is familiar territory to the pharma...
By Kim Ribbink • Dec. 27, 2010
Previous
